Analysis of the Fvl alleles involved in the susceptibility of mice to lactate dehydrogenase-elevating virus-induced polioencephalomyelitis

References

• Anderson G W, Even C, Rowland R R R, Palmer G A, Harty J T, Plagemann P G W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase‐elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J Neurovirol 1995a; 1: 244–252
   PubMed Web of Science ®Google Scholar
• Anderson G W, Palmer G A, Rowland R R R, Even G, Plagemann P G W. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in inutero‐infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase‐elevating virus. J Virol 1995b; 69: 308–319
   Google Scholar
• Bénit L, De Parseval N, Casella J F, Callebaut I, Gordonnier A, Heidmann T. Cloning of a new murine endogenous retrovirus, MuERV.‐L, with strong similarity to the human HERV.‐L element and with a gag coding sequence closely related to the Fv1 restriction gene. J Virol 1997; 71: 5652–5657
   Google Scholar
• Bentley D M, Morris R E. T cell subsets required for protection against age‐dependent polioencephalomyelitis. J Immunol 1982; 128: 530–534
   Google Scholar
• Bentley D M, Watson S R, Morris R E. Age‐related loss of Lyt‐1,2 cells in C58 mice results in susceptibility to lactic dehydrogenase virus‐induced polioencephalomyelitis. Inf Immun 1983; 41: 1389–1390
   Google Scholar
• Best S, Le Tissier P, Towers G, Stoye J P. Positional cloning of the mouse retrovirus restriction gene FV1. Nature (London) 1996; 382: 826–829
   PubMed Web of Science ®Google Scholar
• Chen Z, Li K, Rowland R R R, Plagemann P G W. Selective antibody neutralization prevents neuro‐pathogenic lactate dehydrogenase‐elevating virus from causing paralytic disease in immunocompetent mice. J Neurovirol 1999; 5: 200–208
   Web of Science ®Google Scholar
• Chen Z, Rowland R R R, Anderson G W, Palmer G A, Plagemann P G W. Coexistence in lactate dehydrogenase‐elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J Virol 1997; 71: 2913–2920
   Google Scholar
• Coffin J M. Retrovirus restriction revealed. Nature (London) 1996; 382: 762–763
   Google Scholar
• Contag C H, Plagemann P G W. Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase‐elevating virus correlates with increased expression of endogenous retrovirus in motor neurons. Microb Pathog 1988; 5: 287–296
   Google Scholar
• Contag C H, Plagemann P G W. Age‐dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase‐elevating virus in motor neurons. J Virol 1989; 63: 4362–4369
   PubMed Web of Science ®Google Scholar
• Duffey P S, Martinez D, Abrams G D, Murphy W H. Pathogenic mechanisms in immune polioencephalomyelitis: induction of disease in immunosupp ressed mice. J Immunol 1976; 116: 475–481
   Google Scholar
• Faaberg K S, Palmer G A, Even C, Anderson G W, Plagemann P G W. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase‐elevating virus that differ in neuropathogenicity. Virus Res 1995; 39: 331–340
   Google Scholar
• Godeny E K, Chen L, Kumar S N, Methven S L, Koonin E V, Brinton M A. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase‐elevating virus (LDV). Virology 1993; 194: 585–596
   Google Scholar
• Goff S P. Minireview. Operating under a Gag order: a block against incoming virus by the Fv1 gene. Cell 1996; 86: 691–693
   PubMed Web of Science ®Google Scholar
• Herr W, Gilbert W. Germ‐line MuLV reintegrations in AKR/J mice. Nature (London) 1982; 296: 865–868
   Google Scholar
• Inada T, Kikuchi H, Yamazaki S. Comparison of the ability of lactate dehydrogenase‐elevating virus and its virion RNA to infect murine leukemia virus‐infected or ‐uninfected cell lines. J Virol 1993; 67: 5098–5703
   Google Scholar
• Jolicoeur P. The Fv‐1 gene of the mouse and its control of murine leukemia virus replication. Curr Top Microbiol Immunol 1979; 86: 67–122
   PubMedGoogle Scholar
• Jolicoeur P, Baltimore D. Effect of Fv‐1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc Natl Acad Sci USA 1976; 73: 2236–2240
   Google Scholar
• Kozak C A. Analysis of wild‐derived mice for Fv‐1 and Fv‐2 murine leukemia virus restriction loci: a novel wild mouse Fv‐1 allele responsible for lack of host range restriction. J Virol 1985; 55: 281–285
   Google Scholar
• Kozak C A, Chakraborti A. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. Virology 1996; 225: 300–305
   Google Scholar
• Lilly F, Pincus T. Genetic control of murine viral leukemogenesis. Adv Cancer Res 1973; 17: 231–277
   Google Scholar
• Martinez D, Brinton M A, Tachovsky T G, Phelps A H. Identification of lactate dehydrogenase‐elevating virus as the etiological agent of genetically restricted, age‐dependent polioencephalomyelitis of mice. Infect Immun 1980; 27: 979–987
   Google Scholar
• Mayer A, Duran‐Reynals M L, Lilly F. Fv‐1 regulation of lymphoma development and of thymic, ecotropic and xenotropic MuLV expression in mice of the AKR/J×RF/J cross. Cell 1978; 15: 429–435
   Google Scholar
• Monteyne P, Meite M, Coutelier J P. Involvement of CD4+ cells in the protection of G58 mouse against polioencephalomyelitis induced by lactate dehydrogenase‐elevating virus. J Neurovirol 1997; 3: 380–384
   Web of Science ®Google Scholar
• Murphy W H, Nawrocki J F, Pease L R. Age‐dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease. Prog Brain Res 1983; 59: 291–303
   Google Scholar
• Nawrocki J F, Pease L R, Murphy W H. Etiologic role of lactic dehydrogenase virus infection in an age‐dependent neuroparalytic disease in C5H mice. Virology 1980; 103: 259–264
   Google Scholar
• Odaka T. Inheritance of susceptibility to Friend mouse leukemia virus. V. Introduction of a gene responsible for susceptibility in the genetic complement of resistant mice. J Virol 1969; 3: 543–548
   Google Scholar
• Pease L R, Abrams G D, Murphy W H. FV‐1 restriction of age‐dependent paralytic lactic dehydrogenase virus infection. Virology 1982; 117: 29–37
   Google Scholar
• Pease L R, Murphy W H. Co‐infection by lactic dehydrogenase virus and C‐type retrovirus elicits neurological disease. Nature (London) 1980; 286: 398–400
   Google Scholar
• Pincus T, Hartley J W, Rowe W P. A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses. J Exp Med 1971; 133: 1219–1233
   Google Scholar
• Steeves R, Lilly F. Interactions between host and viral genomes in mouse leukemia. Ann Rev Genet 1977; 11: 277–296
   Google Scholar
• Stroop W G, Brinton M A. Mouse strain‐specific central nervous system lesions associated with lactate dehydrogenase‐elevating virus infection. Lab Invest 1983; 49: 334–345
   Google Scholar